Screen-detected ductal carcinoma in situ, 2008-2020: An observational study.

Caitriona Kelly Patricia FitzpatrickCecily QuinnFidelma FlanaganAlissa ConnorsAideen LarkeTherese MooneyMaria KennedyMargaret SheehanMichael W BennettCaroline BrodieAnn O'Doherty

Published in: Journal of medical screening (2022)

If current clinical trials recommend active surveillance as a feasible option for DCIS, up to 40% of women with screen-detected DCIS may be eligible. These women are younger and often diagnosed on initial screening episode, so may require longer active follow-up.

Keyphrases

clinical trial
high throughput
polycystic ovary syndrome
randomized controlled trial
phase ii
type diabetes
open label
pregnant women
insulin resistance
adipose tissue
single cell